Tian Dai

1.4k total citations
40 papers, 905 citations indexed

About

Tian Dai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tian Dai has authored 40 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Tian Dai's work include Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Bone health and treatments (4 papers). Tian Dai is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Bone health and treatments (4 papers). Tian Dai collaborates with scholars based in United States, China and France. Tian Dai's co-authors include Danielle Jandial, Ying Guo, Leanne L. Seeger, Jean‐Yves Blay, Robert M. Henshaw, Sant P. Chawla, Peter Reichardt, Piotr Rutkowski, Emanuela Palmerini and Keith M. Skubitz and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Tian Dai

39 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tian Dai United States 16 379 231 220 197 126 40 905
Vidya Sankar United States 17 98 0.3× 65 0.3× 89 0.4× 196 1.0× 117 0.9× 42 1.0k
Mark A. Lerman United States 16 309 0.8× 84 0.4× 52 0.2× 134 0.7× 130 1.0× 36 801
Katri Aro Finland 17 469 1.2× 136 0.6× 218 1.0× 29 0.1× 155 1.2× 58 1.3k
Fabio Gallo Italy 18 204 0.5× 198 0.9× 102 0.5× 51 0.3× 22 0.2× 43 960
Lida Radfar United States 19 65 0.2× 86 0.4× 125 0.6× 210 1.1× 64 0.5× 45 1.1k
Daniel Wittschieber Germany 20 184 0.5× 113 0.5× 210 1.0× 79 0.4× 90 0.7× 60 1.3k
Linda Granowetter United States 22 346 0.9× 1.2k 5.3× 136 0.6× 614 3.1× 99 0.8× 48 1.8k
Amy J. Nopper United States 17 558 1.5× 113 0.5× 165 0.8× 135 0.7× 8 0.1× 34 2.7k
Louis Mandel United States 20 189 0.5× 100 0.4× 62 0.3× 150 0.8× 349 2.8× 134 1.6k
Kimberly A. Horii United States 18 474 1.3× 97 0.4× 130 0.6× 89 0.5× 9 0.1× 37 2.3k

Countries citing papers authored by Tian Dai

Since Specialization
Citations

This map shows the geographic impact of Tian Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Dai more than expected).

Fields of papers citing papers by Tian Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Dai. The network helps show where Tian Dai may publish in the future.

Co-authorship network of co-authors of Tian Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Dai. A scholar is included among the top collaborators of Tian Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Dai. Tian Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Wanying, Tian Dai, Daoben Zhu, et al.. (2025). AgNPs-modified IOPC-based flexible SERS patch for rapid label-free analysis of pesticide residues. Sensors and Actuators B Chemical. 442. 138108–138108. 1 indexed citations
2.
Barlési, Fabrice, Enriqueta Felip, Sanjay Popat, et al.. (2024). Sotorasib versus pembrolizumab in combination with platinum doublet chemotherapy as first-line treatment for metastatic or locally advanced, PD-L1 negative, KRAS G12C-mutated NSCLC (CodeBreaK 202).. Journal of Clinical Oncology. 42(16_suppl). TPS8653–TPS8653. 4 indexed citations
3.
Wang, Xuxia, Li Su, Shougang Sun, et al.. (2021). Long-Term Neurological Sequelae and Disease Burden of Japanese Encephalitis in Gansu Province, China. Annals of Global Health. 87(1). 103–103. 10 indexed citations
4.
Skoulidis, Ferdinandos, Martin Schüler, Jennifer Moriatis Wolf, et al.. (2021). MA14.03 Genomic Profiles and Potential Determinants of Response and Resistance in KRAS p.G12C-mutated NSCLC Treated With Sotorasib. Journal of Thoracic Oncology. 16(10). S929–S930. 1 indexed citations
5.
Liu, Shuo, Hui Ju, Feroze Mahmood, et al.. (2021). Pseudoaneurysm of Ascending Aorta induced by Brucella Endocarditis In bicuspid Aortic Valve. Echocardiography. 38(6). 1017–1020. 3 indexed citations
7.
Palmerini, Emanuela, Leanne L. Seeger, Marco Gambarotti, et al.. (2021). Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab. BMC Cancer. 21(1). 89–89. 27 indexed citations
8.
Ramalingam, Suresh S., Marwan Fakih, John H. Strickler, et al.. (2021). Abstract P05-01: A phase 1b study evaluating the safety and efficacy of sotorasib, a KRASG12C inhibitor, in combination with trametinib, a MEK inhibitor, in KRAS p.G12C-Mutated Solid Tumors. Molecular Cancer Therapeutics. 20(12_Supplement). P05–1. 28 indexed citations
9.
Dai, Tian, et al.. (2020). Nasal Pressure Injuries Due to Nasal Continuous Positive Airway Pressure Treatment in Newborns. Journal of Wound Ostomy and Continence Nursing. 47(1). 26–31. 20 indexed citations
10.
Easley, Kirk A., Jason F. Okulicz, Tian Dai, et al.. (2020). CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy. PLoS ONE. 15(1). e0227124–e0227124. 10 indexed citations
11.
Coleman, Robert E., Dianne M. Finkelstein, Carlos H. Barrios, et al.. (2019). Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. The Lancet Oncology. 21(1). 60–72. 158 indexed citations
12.
Xiao, Canhua, et al.. (2019). A Comparison of Missing-Data Imputation Techniques in Exploratory Factor Analysis. Journal of Nursing Measurement. 27(2). 313–334. 5 indexed citations
14.
Wei, Bo, Tian Dai, Limin Peng, Ying Guo, & Amita K. Manatunga. (2019). A new functional representation of broad sense agreement. Statistics & Probability Letters. 158. 108619–108619.
15.
Zhang, Ye, et al.. (2018). The effects of preoperative single-dose thoracic paravertebral block on acute and chronic pain after thoracotomy. Medicine. 97(24). e11181–e11181. 14 indexed citations
17.
Dai, Tian & Ying Guo. (2016). Predicting individual brain functional connectivity using a Bayesian hierarchical model. NeuroImage. 147. 772–787. 14 indexed citations
18.
Hung, Olivia Y., Jennifer R. Brown, Tian Dai, et al.. (2015). Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy. BMJ Open. 5(10). e008350–e008350. 7 indexed citations
19.
Zuñiga, Julie A., et al.. (2015). The Role of Depression in Retention in Care for Persons Living with HIV. AIDS Patient Care and STDs. 30(1). 34–38. 50 indexed citations
20.
Lo, Wei‐Cheng, et al.. (2012). CPred: a web server for predicting viable circular permutations in proteins. Nucleic Acids Research. 40(W1). W232–W237. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026